Keyphrases
Tumor Immunity
100%
Tumor-infiltrating
100%
CD8+ T
100%
Cell Activity
100%
Tumor-draining Lymph Nodes
100%
Interleukin-21 (IL-21)
100%
Cell Density
100%
Effector Function
16%
Subcutaneous Administration
16%
Improved Survival
8%
Activated Lymphocytes
8%
CD8+ T Cells
8%
CD4+CD25+ T Cells
8%
B16 Melanoma
8%
Clinical Development
8%
Renca
8%
Systemic Effects
8%
Tumor Growth
8%
Increased Density
8%
Lymphocyte Count
8%
CD8+
8%
T Cells
8%
Tumor Microenvironment
8%
Renal Cell Carcinoma
8%
Degranulation
8%
Cell Proliferation
8%
Lymphocyte Proliferation
8%
CD25
8%
Syngeneic Mouse Model
8%
CD4+
8%
Cell-mediated
8%
Cancer Treatment
8%
Granzyme B
8%
Tumor
8%
Local Administration
8%
Immunology and Microbiology
Cell Density
100%
Interleukin 21
100%
Lymph Node
100%
Tumor Immunity
100%
Cytotoxic T-Cell
100%
Cell Activity
100%
CD4
16%
CD25
16%
Lymphocyte
16%
CD8
16%
T Cell
16%
Degranulation
8%
Granzyme B
8%
Cytokine
8%
T Cell Proliferation
8%
Interferon
8%
Carcinoma Cell
8%
Syngenic
8%